Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Treasury Shares: 2015-2019

Historic Treasury Shares for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $2,470.

  • Outlook Therapeutics' Treasury Shares fell 84.69% to $2,470 in Q2 2020 from the same period last year, while for Jun 2020 it was $2,470, marking a year-over-year decrease of 84.69%. This contributed to the annual value of $2,470 for FY2019, which is 84.69% down from last year.
  • Outlook Therapeutics' Treasury Shares amounted to $2,470 in FY2019, which was down 84.69% from $16,131 recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Treasury Shares registered a high of $1.1 million during FY2016, and its lowest value of $2,470 during FY2019.
  • Moreover, its 3-year median value for Treasury Shares was $16,131 (2018), whereas its average is $45,362.
  • As far as peak fluctuations go, Outlook Therapeutics' Treasury Shares skyrocketed by 59.29% in 2016, and later slumped by 89.26% in 2017.
  • Over the past 5 years, Outlook Therapeutics' Treasury Shares (Yearly) stood at $687,013 in 2015, then surged by 59.29% to $1.1 million in 2016, then slumped by 89.26% to $117,485 in 2017, then slumped by 86.27% to $16,131 in 2018, then tumbled by 84.69% to $2,470 in 2019.